Mattig, Isabel
Romero Dorta, Elena
Kösters, Lorenz
Fietz, Anne-Katrin
Schulze, Daniel
Sündermann, Simon H.
Brand, Anna
Unbehaun, Axel
Spethmann, Sebastian
Stangl, Karl
Hindricks, Gerhard
Conradi, Lenard
Schäfer, Andreas
Dreger, Henryk https://orcid.org/0000-0003-1909-4329
Funding for this research was provided by:
Abbott, Chicago, Illinois, USA
Charité - Universitätsmedizin Berlin
Article History
Received: 1 February 2026
Accepted: 25 March 2026
First Online: 8 April 2026
Declarations
:
: The study was approved by the ethics committee of the Charité–Universitätsmedizin Berlin, Berlin, Germany (EA4/126/22).
: ERD: advisory board, speaker’s fees, and travel support from Edwards LifeSciences. AB: research funding and speaker’s fees from Medtronic. LC: advisory board for Abbott, JenaValve, Medtronic, consultant for Edwards Lifesciences, BostonScientific, MicroInterventions, MicroPort, PiCardia, smartcanula sarl, VenusMedtech, 4 C Medical. AS: Proctor for Abbott, travel compensation, and speaker’s fee from Abbott. HD: advisory board, research support, and speaker’s fees from Abbott and Edwards LifeSciences. The other authors have nothing to declare.
: Patients were not involved in the study.